Spragens Jeffrey G
SEC CIK 1410620 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SABS | SAB Biotherapeutics, Inc. | Dir | 395.0K | $130.9K | — | 3 | 2021-10-01 | 2022-12-07 |
Most active insiders at SABS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Moin Andrew | Dir | — | — |
| 2 | Kropotova Alexandra | Chief MEDICAL Off | — | — |
| 3 | Sessa Capital GP, LLC | Dir | — | — |
Spragens Jeffrey G made no open-market trades at SABS in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-09 | 2022-12-07 | SABS | SAB Biotherapeutics, Inc. | Spragens Jeffrey G | Dir | A - Grant | $1.21 | +83.0K | 395.0K | +27% | +$100.4K |
| 2022-05-23 | 2022-05-20 | SABS | SAB Biotherapeutics, Inc. | Spragens Jeffrey G | Dir | J - Other | $0.00 | +299.0K | 312.0K | +2,300% | $0 | |
| 2021-10-05 | 2021-10-01 | SABS | SAB Biotherapeutics, Inc. | Spragens Jeffrey G | Dir | P - Purchase | $10.07 | +13.0K | 13.0K | New | +$130.9K |
Purchase Sale Sale after option exercise All abbreviations